ASXC Insider Trading

Insider Ownership Percentage: 2.87%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Asensus Surgical Insider Trading History Chart

This chart shows the insider buying and selling history at Asensus Surgical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$200k-$100k$0$100k$200kTotal Insider BuyingTotal Insider Selling

Asensus Surgical Share Price & Price History

Current Price: $0.35
Price Change: +0.30 (1.20%)
As of 08/22/2024 01:00 AM ET

This chart shows the closing price history over time for ASXC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$0.35Closing price on 04/08/25:

Asensus Surgical Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Asensus Surgical (NYSEAMERICAN:ASXC)

9.35% of Asensus Surgical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ASXC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$400k-$200k$0$200k$400kTotal InflowsTotal Outflows
Asensus Surgical logo
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.
Read More on Asensus Surgical

Today's Range

Now: $0.35
Low: $0.35
High: $0.35

50 Day Range

MA: N/A

52 Week Range

Now: $0.35
Low: $0.17
High: $0.40

Volume

N/A

Average Volume

2,034,864 shs

Market Capitalization

$94.74 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.37

Who are the company insiders with the largest holdings of Asensus Surgical?

Asensus Surgical's top insider shareholders include:
  1. William N Starling Jr (Director)
Learn More about top insider investors at Asensus Surgical.